P&G Files A Third Suit To Stop Generic Actonel
Law360 (April 8, 2008, 12:00 AM EDT) -- In another attempt to block a generic version of its osteoporosis drug Actonel from the market, Procter & Gamble fired off a third suit against Teva Pharmaceutical Industries Ltd. Friday, again...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
